de HaenP., and PearsonR.: Best sources for drug therapy information, Patient Care7: 50–57, Feb. 1, 1973
2.
RosenbergJ. M..: Pharmacist-manned drug information centers are increasing!, Pharmacy Times40: 43–53, June 1974
3.
PearsonR. E..: Michigan regional drug information network - Part I: Concepts. Am. J. Hosp. Pharm.27: 911–913, Nov. 1970
4.
PearsonR. E..: Michigan regional drug information network – Part III: Utilization of information received from a drug information center. Am. J. Hosp. Pharm.29: 229–234, Mar. 1972
5.
PearsonR. E..: Michigan regional drug information network - Part IV: Description and evaluation. Am. J. Hosp. Pharm.29: 312–320, Apr. 1972
6.
PearsonR. E..: Project to develop, evaluate, and deomonstrate a pilot drug information and drug therapy analysis and reporting system: Final report Oct. 1971, Restricted Distribution. (Regional Medical Programs)
7.
HirschmanJ.: Building a clinically-oriented drug information service, pp. 150–177. In: FranckeD. E., and WhitneyH. A. K., Eds., Perspectives in Clinical Pharmacy.Drug IntelligenceHamilton, Ill., 1972
8.
BellR. E..: A new approach to delivering drug information to the physician through a pharmacy consultation program Part I: The Pharmacist; Part II; The Physician, Am. J. Hosp. Pharm.27: 28–37, Jan. 1970
9.
OwenJ. A.: The questionnaire revisited, Hosp. Formul. Manage.9: 29, Aug. 1974
10.
Survey of Drug Information Needs and Problems Associated with Communications Directed to Practicing Physicians, Part I: Physician Information Survey, May 8, 1974, prepared for the Food and Drug Administration, under Contract No. 72–301, by Applied Management Sciences
11.
Monograph on Orphenadrine-Propoxyphene, pp. 115–116. In: Evaluations of Drug Interactions.American Pharmaceutical Association, First Edition, 1973
